Tundra Targeted Therapeutics

Tundra Targeted Therapeutics is a clinical-stage biopharmaceutical company developing novel bispecific antibodies to treat cancer, with a focus on patients who have not responded to or are too vulnerable for current harsh therapies. The company was founded by cancer researchers and clinicians.